Jefferies Group’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-334,100
Closed -$71M 2699
2014
Q4
$71M Sell
334,100
-334,400
-50% -$66.5M 0.42% 46
2014
Q3
$119M Buy
668,500
+181,200
+37% +$30.1M 0.81% 15
2014
Q2
$82.5M Buy
487,300
+410,300
+533% +$63.9M 0.7% 21
2014
Q1
$9.56M Buy
+77,000
New +$9.38M 0.09% 172
2013
Q4
Sell
-7,800
Closed -$706K 2536
2013
Q3
$706K Sell
7,800
-122,800
-94% -$11M 0.01% 1069
2013
Q2
$11M Buy
+130,600
New +$13.5M 0.12% 128

Other funds holding AGN

Jefferies Group's AGN Position: Q1 2015 in Review

Jefferies Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 371,237 shares — an estimated $78.9M sold.

Jefferies Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $78.9M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Jefferies Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Jefferies Group sold 371,237 Allergan Inc shares in Q1 2015, an estimated $78.9M.
  • Jefferies Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Jefferies Group's Allergan Inc position peaked at $78.9M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Jefferies Group's 13F filing for Q1 2015, filed 18 May 2015.